CN113729009A - 一种宫颈细胞保存液及其制备方法和保存方法 - Google Patents
一种宫颈细胞保存液及其制备方法和保存方法 Download PDFInfo
- Publication number
- CN113729009A CN113729009A CN202111196651.9A CN202111196651A CN113729009A CN 113729009 A CN113729009 A CN 113729009A CN 202111196651 A CN202111196651 A CN 202111196651A CN 113729009 A CN113729009 A CN 113729009A
- Authority
- CN
- China
- Prior art keywords
- solution
- preservation solution
- superior food
- preservation
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003761 preservation solution Substances 0.000 title claims abstract description 43
- 238000004321 preservation Methods 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 30
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims abstract description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 14
- 241001122767 Theaceae Species 0.000 claims abstract description 13
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims abstract description 13
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 13
- 229930182490 saponin Natural products 0.000 claims abstract description 13
- 150000007949 saponins Chemical class 0.000 claims abstract description 13
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims abstract description 11
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract description 11
- 235000019796 monopotassium phosphate Nutrition 0.000 claims abstract description 11
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims abstract description 10
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 10
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims abstract description 10
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 10
- 239000011780 sodium chloride Substances 0.000 claims abstract description 10
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 8
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000001103 potassium chloride Substances 0.000 claims abstract description 7
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 78
- 210000003097 mucus Anatomy 0.000 abstract description 18
- 238000001514 detection method Methods 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 238000003860 storage Methods 0.000 abstract description 9
- 210000003743 erythrocyte Anatomy 0.000 abstract description 6
- 210000000265 leukocyte Anatomy 0.000 abstract description 5
- 231100000252 nontoxic Toxicity 0.000 abstract description 4
- 230000003000 nontoxic effect Effects 0.000 abstract description 4
- 238000005336 cracking Methods 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 33
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 238000010186 staining Methods 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 6
- 206010008342 Cervix carcinoma Diseases 0.000 description 5
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 5
- 201000010881 cervical cancer Diseases 0.000 description 5
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 241000700605 Viruses Species 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000701806 Human papillomavirus Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
对比例1 | 对比例2 | 对比例3 | 对比例4 | 对比例5 | 对比例6 | |
pH | 6.5 | 6.5 | 6.5 | 6.5 | 6.5 | 6.5 |
pH | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 |
实验方法 | 细胞量 | 形态及种类 | 白细胞数量 | 粘液情况 | 血液情况 |
实施例1 | 优 | 优 | 优 | 优 | 优 |
实施例2 | 优 | 优 | 优 | 优 | 优 |
实施例3 | 优 | 优 | 优 | 优 | 优 |
实施例4 | 优 | 优 | 优 | 优 | 优 |
实施例5 | 优 | 优 | 优 | 优 | 优 |
实施例6 | 优 | 优 | 优 | 优 | 优 |
对比例1 | 优 | 一般 | 优 | 优 | 一般 |
对比例2 | 优 | 一般 | 优 | 优 | 一般 |
对比例3 | 优 | 一般 | 优 | 优 | 一般 |
对比例4 | 优 | 一般 | 优 | 优 | 一般 |
对比例5 | 优 | 一般 | 优 | 优 | 一般 |
对比例6 | 优 | 一般 | 优 | 优 | 一般 |
实验方法 | 细胞量 | 形态及种类 | 白细胞数量 | 粘液情况 | 血液情况 |
实施例1 | 优 | 优 | 优 | 优 | 优 |
实施例2 | 优 | 优 | 优 | 优 | 优 |
实施例3 | 优 | 优 | 优 | 优 | 优 |
实施例4 | 优 | 优 | 优 | 优 | 优 |
实施例5 | 优 | 优 | 优 | 优 | 优 |
实施例6 | 优 | 优 | 优 | 优 | 优 |
对比例1 | 优 | 一般 | 一般 | 优 | 一般 |
对比例2 | 优 | 一般 | 一般 | 优 | 一般 |
对比例3 | 优 | 一般 | 一般 | 优 | 一般 |
对比例4 | 优 | 一般 | 一般 | 优 | 一般 |
对比例5 | 优 | 一般 | 一般 | 优 | 一般 |
对比例6 | 优 | 一般 | 一般 | 优 | 一般 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111196651.9A CN113729009B (zh) | 2021-10-14 | 2021-10-14 | 一种宫颈细胞保存液及其制备方法和保存方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111196651.9A CN113729009B (zh) | 2021-10-14 | 2021-10-14 | 一种宫颈细胞保存液及其制备方法和保存方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113729009A true CN113729009A (zh) | 2021-12-03 |
CN113729009B CN113729009B (zh) | 2022-12-16 |
Family
ID=78726573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111196651.9A Active CN113729009B (zh) | 2021-10-14 | 2021-10-14 | 一种宫颈细胞保存液及其制备方法和保存方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113729009B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114149960A (zh) * | 2021-12-03 | 2022-03-08 | 山东高创医疗器械国家研究院有限公司 | 样本密度分离液及细胞分离方法 |
CN115868480A (zh) * | 2022-12-30 | 2023-03-31 | 广州普希盛科技有限公司 | 一种细胞保存液及液态细胞质控品的制备方法和应用 |
WO2023056726A1 (zh) * | 2021-10-08 | 2023-04-13 | 广州达安基因股份有限公司 | 一种液基细胞保存液及其配制方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102258003A (zh) * | 2010-05-28 | 2011-11-30 | 孝感市中心医院 | 一种液基细胞保存液 |
CN105409925A (zh) * | 2014-09-19 | 2016-03-23 | 孝感宏翔生物医械技术有限公司 | 一种液基细胞保存液 |
CN106047795A (zh) * | 2016-06-22 | 2016-10-26 | 杭州海世嘉生物科技有限公司 | 一种样本密度分离液及其制备方法 |
CN108849850A (zh) * | 2017-05-11 | 2018-11-23 | 武汉宏强医疗器械有限公司 | 一种人体宫颈脱落细胞保存液 |
CN110352950A (zh) * | 2018-04-10 | 2019-10-22 | 南京福怡科技发展股份有限公司 | 一种具有预处理功能非宫颈脱落细胞保存液及应用 |
CN110742059A (zh) * | 2019-11-27 | 2020-02-04 | 武汉医尔特科技有限公司 | 一种液基细胞保存液及其制备方法 |
-
2021
- 2021-10-14 CN CN202111196651.9A patent/CN113729009B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102258003A (zh) * | 2010-05-28 | 2011-11-30 | 孝感市中心医院 | 一种液基细胞保存液 |
CN105409925A (zh) * | 2014-09-19 | 2016-03-23 | 孝感宏翔生物医械技术有限公司 | 一种液基细胞保存液 |
CN106047795A (zh) * | 2016-06-22 | 2016-10-26 | 杭州海世嘉生物科技有限公司 | 一种样本密度分离液及其制备方法 |
CN108849850A (zh) * | 2017-05-11 | 2018-11-23 | 武汉宏强医疗器械有限公司 | 一种人体宫颈脱落细胞保存液 |
CN110352950A (zh) * | 2018-04-10 | 2019-10-22 | 南京福怡科技发展股份有限公司 | 一种具有预处理功能非宫颈脱落细胞保存液及应用 |
CN110742059A (zh) * | 2019-11-27 | 2020-02-04 | 武汉医尔特科技有限公司 | 一种液基细胞保存液及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023056726A1 (zh) * | 2021-10-08 | 2023-04-13 | 广州达安基因股份有限公司 | 一种液基细胞保存液及其配制方法 |
CN114149960A (zh) * | 2021-12-03 | 2022-03-08 | 山东高创医疗器械国家研究院有限公司 | 样本密度分离液及细胞分离方法 |
CN115868480A (zh) * | 2022-12-30 | 2023-03-31 | 广州普希盛科技有限公司 | 一种细胞保存液及液态细胞质控品的制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN113729009B (zh) | 2022-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113729009B (zh) | 一种宫颈细胞保存液及其制备方法和保存方法 | |
CN107509722B (zh) | 样本保存液 | |
CN108770836A (zh) | 液基细胞保存液及其制备方法和应用 | |
CN113383769B (zh) | 一种细胞保存液及其制备方法与应用 | |
CN103120153A (zh) | 一种脱落细胞保存液 | |
CN105368817B (zh) | 宫颈细胞保存及dna快速提取一体试剂盒和提取方法 | |
CN112640888B (zh) | 细胞保存液及其制备方法与细胞的保存方法 | |
CN108849850A (zh) | 一种人体宫颈脱落细胞保存液 | |
CN109612800B (zh) | 一种非妇科液基标本的制片方法 | |
CN103884549B (zh) | 一种痰细胞处理液及其应用 | |
CN107271246B (zh) | 一种用于液基薄层细胞的免疫p16INK4a抗原保存液及其制备方法 | |
CN112741080B (zh) | 一种液基细胞保存处理液及其制备方法和应用 | |
CN111024471A (zh) | 一种用于宫颈癌筛查的液基细胞检测试剂盒及使用方法 | |
CN111238889A (zh) | 一种基于制片法的液基真菌检测方法 | |
CN113068683B (zh) | 一种液基细胞检查用细胞保存液及其制备方法 | |
KR102563528B1 (ko) | 자궁 경부암 액상 세포 검사용 솔루션 조성물 | |
CN111972396A (zh) | 宫颈脱落细胞保存液及制备方法和细胞保存方法 | |
CN114223649B (zh) | 花色苷在冷冻保存精子中的应用、精子冷冻保存液 | |
CN116649330B (zh) | 一种液基脱落细胞保存液、试剂盒及应用 | |
Alogayli et al. | A comparative Between Different Urine Fixation Methods for Cytological Examination | |
CN114149960A (zh) | 样本密度分离液及细胞分离方法 | |
CN116195575A (zh) | 一种液基细胞保存液及其制备方法和应用 | |
CN114279797A (zh) | 一种骨髓活检固定液及其制备方法 | |
CN114323903A (zh) | 一种脱落细胞的处理试剂、制备方法及其使用方法和应用 | |
Elezi et al. | CORRELATION BETWEEN BIOCHEMICAL ANALYSIS AND THE CYTOLOGY OF URINE SEDIMENT SMEARS STAINED BY GIEMSA METHODS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Mingwei Inventor after: Liu Meijing Inventor after: Sun Xinxin Inventor after: Li Jing Inventor after: Sheng Chunhai Inventor after: Lan Haohui Inventor before: Zhang Mingwei Inventor before: Liu Meijing Inventor before: Sun Xinxin Inventor before: Li Jing Inventor before: Sheng Chunhai Inventor before: Lan Haohui |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231114 Address after: No. 1 Weigao Road, Torch High tech Industrial Development Zone, Weihai City, Shandong Province, 264200 Patentee after: Shandong Weigaoruixin Medical Technology Co.,Ltd. Address before: 264210 No. 288-1, Shanhai Road, torch high tech Industrial Development Zone, Weihai City, Shandong Province Patentee before: SHANDONG GAOCHUANG MEDICAL DEVICE NATIONAL RESEARCH INSTITUTE Co.,Ltd. |
|
TR01 | Transfer of patent right |